Abstract:Background: β-adrenergic receptor (β-AR) overactivation is a major pathological cue associated with cardiac injury and diseases. AMPK (AMP-activated protein kinase), a conserved energy sensor, regulates energy metabolism and is cardioprotective. However, whether AMPK exerts cardioprotective effects via regulating the signaling pathway downstream of β-AR remains unclear. Methods: Using immunoprecipitation, mass spectrometry, site-specific mutation, in vitro kinase assay, and in vivo animal studies, we determined whether AMPK phosphorylates β-arrestin-1 at serine (Ser) 330. Wild-type mice and mice with site-specific mutagenesis (S330A knock-in [KI]/S330D KI) were subcutaneously injected with the β-AR agonist isoproterenol (5 mg/kg) to evaluate the causality between β-adrenergic insult and β-arrestin-1 Ser330 phosphorylation. Cardiac transcriptomics was used to identify changes in gene expression from β-arrestin-1-S330A/S330D mutation and β-adrenergic insult. Results: Metformin could decrease cAMP/PKA (protein kinase A) signaling induced by isoproterenol. AMPK bound to β-arrestin-1 and phosphorylated Ser330 with the highest phosphorylated mass spectrometry score. AMPK activation promoted β-arrestin-1 Ser330 phosphorylation in vitro and in vivo. Neonatal mouse cardiomyocytes overexpressing β-arrestin-1-S330D (active form) inhibited the β-AR/cAMP/PKA axis by increasing PDE (phosphodiesterase) 4 expression and activity. Cardiac transcriptomics revealed that the differentially expressed genes between isoproterenol-treated S330A KI and S330D KI mice were mainly involved in immune processes and inflammatory response. β-arrestin-1 Ser330 phosphorylation inhibited isoproterenol-induced reactive oxygen species production and NLRP3 (NOD-like receptor protein 3) inflammasome activation in neonatal mouse cardiomyocytes. In S330D KI mice, the β-AR-activated cAMP/PKA pathways were attenuated, leading to repressed inflammasome activation, reduced expression of proinflammatory cytokines, and mitigated macrophage infiltration. Compared with S330A KI mice, S330D KI mice showed diminished cardiac fibrosis and improved cardiac function upon isoproterenol exposure. However, the cardiac protection exerted by AMPK was abolished in S330A KI mice. Conclusions: AMPK phosphorylation of β-arrestin-1 Ser330 potentiated PDE4 expression and activity, thereby inhibiting β-AR/cAMP/PKA activation. Subsequently, β-arrestin-1 Ser330 phosphorylation blocks β-AR-induced cardiac inflammasome activation and remodeling.

Quantitative Analysis of the Cardiac Phosphoproteome in Response to Acute -Adrenergic Receptor Stimulation In Vivo

Phosphoproteome Analysis of Cardiomyocytes Subjected to Β-Adrenergic Stimulation

Identification of Proteins Responding to Adrenergic Receptor Subtype-Specific Hypertrophy in Cardiomyocytes by Proteomic Approaches.

Differential Proteomic Analysis of Neonatal Cardiomyocytes in Response to Β-Adrenergic Receptor Stimulation

[Effects of Beta-Adrenoceptor Activation on Metabolism in Neonatal Rat Cardiomyocytes].

Proteomic Profiling Reveals Comprehensive Insights into Adrenergic Receptor-Mediated Hypertrophy in Neonatal Rat Cardiomyocytes.

Proteomics of Acute Heart Failure in a Rat Post-Myocardial Infarction Model

Decreased long-chain acyl-CoA dehydrogenase mediates cardiac energy deficiency and injury induced by β-adrenergic stimulation

Reprogramming of cardiac phosphoproteome, proteome, and transcriptome confers resilience to chronic adenylyl cyclase-driven stress

Proteomic Analysis of Cardiac Adaptation to Exercise by High Resolution Mass Spectrometry

Intracellular β1-Adrenergic Receptors and Organic Cation Transporter 3 Mediate Phospholamban Phosphorylation to Enhance Cardiac Contractility

S100A1 Transgenic Treatment of Acute Heart Failure Causes Proteomic Changes in Rats.

Protecting The Myocardium: A Role For The Beta 2 Adrenergic Receptor In The Heart

AMPK Attenuation of β-Adrenergic Receptor-Induced Cardiac Injury via Phosphorylation of β-Arrestin-1-ser330

The Myocardial Response to Adrenomedullin Involves Increased Camp Generation As Well As Augmented Akt Phosphorylation

Intracellular Β 1 -Adrenergic Receptors and Organic Cation Transporter 3 Mediate Phospholamban Phosphorylation to Enhance Cardiac Contractility

Revealing the Dynamics of the 20 S Proteasome Phosphoproteome: A Combined CID and Electron Transfer Dissociation Approach

Abstract 19829: PKIalpha Modulates Adrenergic Signaling in Cardiac Physiology and Pathophysiology

Quantitative phosphoproteomic analysis reveals unique cAMP signaling pools emanating from AC2 and AC6 in human airway smooth muscle cells

Transgenic Manipulation of Beta-Adrenergic Receptor Kinase Modifies Cardiac Myocyte Contraction to Norepinephrine.

Abstract 17498: PKA is the Canonical Mediator of “Fight-or-flight” Response of the Heart